Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mai

Showing results (21-30 of 307) with videos related to

Pageof 31
Sort By:
Nihon Geka Gakkai Zasshi|June 8, 2001
[Significance of angiogenesis and clinical application of anti-angiogenesis]Y Takahashi, M Mai
Nihon Geka Gakkai Zasshi|September 1, 1994
[Surgical treatment and adjuvant therapy of patients with neoplasms]M Mai, T Toge
Journal of Paediatrics and Child Health|July 15, 1999
Meningitis or madness: a delicate balanceT Duke, M Mai
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 1, 2000
[Significance of prolonged NC as an endpoint of chemotherapy for solid tumors]Y Takahashi, M Mai
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 27, 2001
[New molecular markers for prognosis of gastric cancer]Y Takahashi, M Mai
Human Cell|June 1, 1993
[Prediction of recurrence of gastrointestinal cancer from standpoint of biological malignancies--tumor marker doubling time and its a half life period line]M Mai, Y Takahashi
Journal of Experimental & Clinical Cancer Research : CR|August 23, 2005
Antibody against vascular endothelial growth factor (VEGF) inhibits angiogenic switch and liver metastasis in orthotopic xenograft model with site-dependent expression of VEGFY Takahashi, M Mai
The Journal of the Royal College of Physicians of Edinburgh|January 12, 2007
Beethoven's terminal illness and deathF M M Mai
The American Journal of Gastroenterology|December 17, 1997
Enhanced expression of CA19-9 in mucinous gastric carcinomaH Nomura, M Mai
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1991
[Tumor markers--personal experience. How to read time course of some values and tumor marker doubling time]Y Takahashi, M Mai
Pageof 31

Showing results (21-30 of 307) with videos related to

Sort By:
Pageof 31
Nihon Geka Gakkai Zasshi|June 8, 2001
[Significance of angiogenesis and clinical application of anti-angiogenesis]Y Takahashi, M Mai
Nihon Geka Gakkai Zasshi|September 1, 1994
[Surgical treatment and adjuvant therapy of patients with neoplasms]M Mai, T Toge
Journal of Paediatrics and Child Health|July 15, 1999
Meningitis or madness: a delicate balanceT Duke, M Mai
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 1, 2000
[Significance of prolonged NC as an endpoint of chemotherapy for solid tumors]Y Takahashi, M Mai
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 27, 2001
[New molecular markers for prognosis of gastric cancer]Y Takahashi, M Mai
Human Cell|June 1, 1993
[Prediction of recurrence of gastrointestinal cancer from standpoint of biological malignancies--tumor marker doubling time and its a half life period line]M Mai, Y Takahashi
Journal of Experimental & Clinical Cancer Research : CR|August 23, 2005
Antibody against vascular endothelial growth factor (VEGF) inhibits angiogenic switch and liver metastasis in orthotopic xenograft model with site-dependent expression of VEGFY Takahashi, M Mai
The Journal of the Royal College of Physicians of Edinburgh|January 12, 2007
Beethoven's terminal illness and deathF M M Mai
The American Journal of Gastroenterology|December 17, 1997
Enhanced expression of CA19-9 in mucinous gastric carcinomaH Nomura, M Mai
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1991
[Tumor markers--personal experience. How to read time course of some values and tumor marker doubling time]Y Takahashi, M Mai
Pageof 31